Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Approval for New Clinical Manufacturing Site

Published: Thursday, July 18, 2013
Last Updated: Thursday, July 18, 2013
Bookmark and Share
Completes successful MHRA inspection.

UK-BASED contract research and manufacturing organization Molecular Profiles has opened the doors of its new facility following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA).

The Nottingham-based, £9 million pharmaceutical production site will give drug development companies across the world access to the clinical manufacturing capabilities.

Designed to handle a range of non-sterile dosage forms such as solids, liquids, semi-solids and inhaled products, Molecular Profiles’ new 30,000sq ft. facility marks a significant expansion for the company that started life as a spin-out from Nottingham University over 15 years ago.

The investment adds six GMP suites, new laboratories and a dedicated clinical packing area to support clients’ Phase I and II clinical trial projects.

The facility also allows for the manufacture of highly potent compounds up to OEB 4 level with manufacturing batch scale of up to 30kg.

Nikin Patel, CEO at Molecular Profiles, said: “Receiving our license from the MHRA for our new site is probably the biggest milestone for our business since we set-up shop so is naturally a very exciting time for everyone involved.

“From a commercial perspective, we are very much open for business and have already received significant interest from companies looking to use our manufacturing capabilities to assist with their clinical trial requirements.”

The official approval of the company’s cGMP-compliant facility follows a recent high-profile visit from the Honourable Nick Clegg, Deputy Prime Minister of the UK Government, which provided £1.6m to the expansion through the regional growth fund grant.

The company’s vice president Steve Kemp added: “We have enjoyed a sustained and gradual period of growth over the last decade driven by our consulting, formulation development and analytical services but we are expecting our expanded manufacturing facilities to take us to the next level by helping us better compete on a global scale.”

Having a dedicated manufacturing site complements Molecular Profiles’ established formulation development expertise.

Furthermore, it supports its strategic alliance with Onyx Scientific, which is aimed at delivering end-to-end pharmaceutical development services from initial drug discovery through to the later phases of clinical development.

Founded by a group of scientists, Molecular Profiles now works with leading pharmaceutical companies across the globe and specializes in advanced characterization, R&D and manufacturing services.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Profiles, Xceleron Drug Development Partnership
Companies announce a collaboration to assist drug developers with improved efficiency during clinical development.
Saturday, November 01, 2014
Molecular Profiles Strengthens Capsule Capability
Adds capsule bander for liquid filling and a second capsule filling machine.
Thursday, September 11, 2014
Molecular Profiles, XenoGesis Collaborate
Partnership will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage.
Monday, August 04, 2014
Molecular Profiles Joins Leading Consortium to Drive Paediatric Formulation Development
UK-wide consortium has received a £660k grant from the Technology Strategy Board.
Friday, December 27, 2013
Molecular Profiles and Onyx Scientific Form Strategic Alliance
New alliance offers fully integrated services from drug discovery through to late phase clinical trial manufacturing.
Tuesday, August 14, 2012
CEO of Molecular Profiles Recognized as One of 100 Most Inspiring People in the Life Sciences Industry
Nikin Patel has been acknowledged as one of PharmaVOICE magazine's top 100 most inspiring individuals in the life sciences industry.
Tuesday, August 09, 2011
Molecular Profiles Expands Service Offering with new Manufacturing Capabilities
The manufacturing capabilities enables the company to handle larger projects for pharmaceutical clients from preformulation through to Phase IIa.
Tuesday, January 18, 2011
Molecular Profiles Wins the Queen’s Award for Enterprise in 2007 in the Category of Innovation
The award recognizes Molecular Profiles’ contract research services which encompass the company’s knowledge and skills in advanced analytical techniques.
Monday, April 23, 2007
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
“Sixth Sense” May Be More Than Just A Feeling
The NIH Study shows that two young patients with a mutation in the PIEZ02 have problems with touch and proprioception, or body awareness.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Plant Pathogens with RNA
Researchers develop strategy that could lead to environmentally friendly fungicide to fight pathogens.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!